Cite Filings / SABS / 0000950170-22-018255

Feed Companies Filings Check

Sign in

SC 13D/A

Beneficial Ownership Report

SAB Biotherapeutics, Inc. Filed 2022-09-08 Acc 0000950170-22-018255

Documents 1

SC 13D/A Beneficial Ownership Report , sabs__sc_13da__sullivan.htm

Around this filing

2022-12-16 SC 13D/A Beneficial Ownership Report
2022-09-15 4 Options or other derivatives
2022-09-15 4 Options or other derivatives
2022-09-14 4 Director bought 10,000 shares at $0.73 ($7,297)
2022-09-08 4 CHIEF EXECUTIVE OFFICER bought 14,000 shares at $0.74 ($10,315)
2022-09-08 SC 13D/A Beneficial Ownership Report
2022-09-08 SC 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading sabs__sc_13da__sullivan.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…